$PDLI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PDL BIOPHARMA, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in PDL BIOPHARMA, INC.. Get notifications about new insider transactions in PDL BIOPHARMA, INC. for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 ... 11 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 27 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 20.25 | 219 | 4,435 | 874 | 1.1 K to 874 (-20.04 %) |
Mar 27 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 20.18 | 218 | 4,399 | 1,093 | 1.3 K to 1.1 K (-16.63 %) |
Mar 27 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 20.17 | 219 | 4,417 | 1,311 | 1.5 K to 1.3 K (-14.31 %) |
Mar 27 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 20.14 | 438 | 8,821 | 1,530 | 2 K to 1.5 K (-22.26 %) |
Mar 27 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 20.13 | 219 | 4,408 | 1,968 | 2.2 K to 2 K (-10.01 %) |
Mar 27 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Buy | M | 15.73 | 2,187 | 34,402 | 2,187 | 0 to 2.2 K |
Feb 23 2007 | PDLI | PDL BIOPHARMA, INC ... | McCamish Mark Anthony | SVP & CMO | Option Exercise | A | 19.14 | 85,000 | 1,626,900 | 85,000 | |
Feb 23 2007 | PDLI | PDL BIOPHARMA, INC ... | McCamish Mark Anthony | SVP & CMO | Grant | A | 0.00 | 7,500 | 0 | 7,500 | 0 to 7.5 K |
Feb 20 2007 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | EVP & CSO | Option Exercise | A | 19.32 | 100,000 | 1,932,000 | 100,000 | |
Feb 20 2007 | PDLI | PDL BIOPHARMA, INC ... | Goodwin Bradford S | Director | Option Exercise | A | 19.32 | 3,000 | 57,960 | 3,000 | |
Feb 16 2007 | PDLI | PDL BIOPHARMA, INC ... | GUGGENHIME ANDREW | SVP & Chief Financ ... | Option Exercise | A | 19.00 | 20,000 | 380,000 | 20,000 | |
Jan 29 2007 | PDLI | PDL BIOPHARMA, INC ... | Calcott Peter H | VP, Quality & Comp ... | Sell | S | 20.47 | 670 | 13,715 | 1,875 | 2.5 K to 1.9 K (-26.33 %) |
Jan 25 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Option Exercise | M | 15.73 | 2,187 | 34,402 | 56,880 | |
Jan 25 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 21.41 | 2 | 43 | 0 | 2 to 0 (-100.00 %) |
Jan 25 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 21.40 | 216 | 4,622 | 2 | 218 to 2 (-99.08 %) |
Jan 25 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 21.39 | 218 | 4,663 | 218 | 436 to 218 (-50.00 %) |
Jan 25 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 21.36 | 218 | 4,656 | 436 | 654 to 436 (-33.33 %) |
Jan 25 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 21.35 | 436 | 9,309 | 654 | 1.1 K to 654 (-40.00 %) |
Jan 25 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 21.34 | 218 | 4,652 | 1,090 | 1.3 K to 1.1 K (-16.67 %) |
Jan 25 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 21.30 | 218 | 4,643 | 1,308 | 1.5 K to 1.3 K (-14.29 %) |
Jan 25 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 21.29 | 661 | 14,073 | 1,526 | 2.2 K to 1.5 K (-30.22 %) |
Jan 25 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Buy | M | 15.73 | 2,187 | 34,402 | 2,187 | 0 to 2.2 K |
Jan 19 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Option Exercise | M | 8.30 | 10,000 | 83,000 | 500,000 | |
Jan 19 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 21.46 | 2,300 | 49,358 | 53,137 | 55.4 K to 53.1 K (-4.15 %) |
Jan 19 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 21.45 | 7,700 | 165,165 | 55,437 | 63.1 K to 55.4 K (-12.20 %) |
Jan 19 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Buy | M | 8.30 | 10,000 | 83,000 | 63,137 | 53.1 K to 63.1 K (+18.82 %) |
Jan 22 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Option Exercise | M | 17.13 | 645 | 11,049 | 27,775 | |
Jan 22 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 22.00 | 645 | 14,190 | 0 | 645 to 0 (-100.00 %) |
Jan 22 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Buy | M | 17.13 | 645 | 11,049 | 645 | 0 to 645 |
Jan 18 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Option Exercise | M | 8.30 | 10,000 | 83,000 | 510,000 | |
Jan 18 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 21.30 | 5,000 | 106,500 | 53,137 | 58.1 K to 53.1 K (-8.60 %) |
Jan 18 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 21.29 | 2,000 | 42,580 | 58,137 | 60.1 K to 58.1 K (-3.33 %) |
Jan 18 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 21.27 | 3,000 | 63,810 | 60,137 | 63.1 K to 60.1 K (-4.75 %) |
Jan 18 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Buy | M | 8.30 | 10,000 | 83,000 | 63,137 | 53.1 K to 63.1 K (+18.82 %) |
Jan 17 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Option Exercise | M | 8.30 | 10,000 | 83,000 | 520,000 | |
Jan 17 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.82 | 1,000 | 20,817 | 53,137 | 54.1 K to 53.1 K (-1.85 %) |
Jan 17 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.81 | 200 | 4,162 | 54,137 | 54.3 K to 54.1 K (-0.37 %) |
Jan 17 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Buy | S | 20.80 | 800 | 16,640 | 54,337 | 53.5 K to 54.3 K (+1.49 %) |
Jan 17 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.94 | 2,000 | 41,880 | 55,137 | 57.1 K to 55.1 K (-3.50 %) |
Jan 17 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.93 | 1,000 | 20,930 | 57,137 | 58.1 K to 57.1 K (-1.72 %) |
Jan 17 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.92 | 1,000 | 20,920 | 58,137 | 59.1 K to 58.1 K (-1.69 %) |
Jan 17 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.90 | 1,000 | 20,900 | 59,137 | 60.1 K to 59.1 K (-1.66 %) |
Jan 17 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.90 | 900 | 18,806 | 60,137 | 61 K to 60.1 K (-1.47 %) |
Jan 17 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.89 | 1,100 | 22,979 | 61,037 | 62.1 K to 61 K (-1.77 %) |
Jan 17 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.87 | 1,000 | 20,870 | 62,137 | 63.1 K to 62.1 K (-1.58 %) |
Jan 17 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Buy | M | 8.30 | 10,000 | 83,000 | 63,137 | 53.1 K to 63.1 K (+18.82 %) |
Jan 16 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Option Exercise | M | 8.30 | 10,000 | 83,000 | 530,000 | |
Jan 16 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.85 | 1,500 | 31,277 | 53,137 | 54.6 K to 53.1 K (-2.75 %) |
Jan 16 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.83 | 1,500 | 31,245 | 54,637 | 56.1 K to 54.6 K (-2.67 %) |
Jan 16 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.82 | 1,500 | 31,230 | 56,137 | 57.6 K to 56.1 K (-2.60 %) |
Jan 16 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.73 | 1,500 | 31,095 | 57,637 | 59.1 K to 57.6 K (-2.54 %) |
Jan 16 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.66 | 1,000 | 20,660 | 59,137 | 60.1 K to 59.1 K (-1.66 %) |
Jan 16 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.55 | 1,500 | 30,825 | 60,137 | 61.6 K to 60.1 K (-2.43 %) |
Jan 16 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.49 | 1,500 | 30,735 | 61,637 | 63.1 K to 61.6 K (-2.38 %) |
Jan 16 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Buy | M | 8.30 | 10,000 | 83,000 | 63,137 | 53.1 K to 63.1 K (+18.82 %) |
Jan 12 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Option Exercise | M | 8.30 | 10,000 | 83,000 | 540,000 | |
Jan 12 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.50 | 1,500 | 30,750 | 53,137 | 54.6 K to 53.1 K (-2.75 %) |
Jan 12 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.44 | 1,529 | 31,253 | 54,637 | 56.2 K to 54.6 K (-2.72 %) |
Jan 12 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.43 | 2,875 | 58,736 | 56,166 | 59 K to 56.2 K (-4.87 %) |
Jan 12 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.41 | 96 | 1,959 | 59,041 | 59.1 K to 59 K (-0.16 %) |
Jan 12 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.38 | 600 | 12,228 | 59,137 | 59.7 K to 59.1 K (-1.00 %) |
Jan 12 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.37 | 57 | 1,161 | 59,737 | 59.8 K to 59.7 K (-0.10 %) |
Jan 12 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.35 | 1,943 | 39,540 | 59,794 | 61.7 K to 59.8 K (-3.15 %) |
Jan 12 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.33 | 1,400 | 28,462 | 61,737 | 63.1 K to 61.7 K (-2.22 %) |
Jan 12 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Buy | M | 8.30 | 10,000 | 83,000 | 63,137 | 53.1 K to 63.1 K (+18.82 %) |
Jan 10 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Option Exercise | M | 8.30 | 10,000 | 83,000 | 550,000 | |
Jan 10 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Option Exercise | M | 8.30 | 10,000 | 83,000 | 560,000 | |
Jan 10 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.38 | 800 | 16,304 | 53,137 | 53.9 K to 53.1 K (-1.48 %) |
Jan 10 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.36 | 2,000 | 40,720 | 53,937 | 55.9 K to 53.9 K (-3.58 %) |
Jan 10 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.30 | 2,200 | 44,660 | 55,937 | 58.1 K to 55.9 K (-3.78 %) |
Jan 10 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.28 | 2,000 | 40,560 | 58,137 | 60.1 K to 58.1 K (-3.33 %) |
Jan 10 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.26 | 2,200 | 44,572 | 60,137 | 62.3 K to 60.1 K (-3.53 %) |
Jan 10 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.25 | 800 | 16,200 | 62,337 | 63.1 K to 62.3 K (-1.27 %) |
Jan 10 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Buy | M | 8.30 | 10,000 | 83,000 | 63,137 | 53.1 K to 63.1 K (+18.82 %) |
Jan 10 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.51 | 100 | 2,051 | 53,137 | 53.2 K to 53.1 K (-0.19 %) |
Jan 10 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.47 | 1,000 | 20,470 | 53,237 | 54.2 K to 53.2 K (-1.84 %) |
Jan 10 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.46 | 1,000 | 20,460 | 54,237 | 55.2 K to 54.2 K (-1.81 %) |
Jan 10 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.45 | 1,000 | 20,450 | 55,237 | 56.2 K to 55.2 K (-1.78 %) |
Jan 10 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.44 | 2,000 | 40,880 | 56,237 | 58.2 K to 56.2 K (-3.43 %) |
Jan 10 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.43 | 100 | 2,043 | 58,237 | 58.3 K to 58.2 K (-0.17 %) |
Jan 10 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.41 | 800 | 16,328 | 58,337 | 59.1 K to 58.3 K (-1.35 %) |
Jan 10 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.40 | 2,000 | 40,800 | 59,137 | 61.1 K to 59.1 K (-3.27 %) |
Jan 10 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.36 | 700 | 14,255 | 61,137 | 61.8 K to 61.1 K (-1.13 %) |
Jan 10 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.36 | 1,300 | 26,468 | 61,837 | 63.1 K to 61.8 K (-2.06 %) |
Jan 10 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Buy | M | 8.30 | 10,000 | 83,000 | 63,137 | 53.1 K to 63.1 K (+18.82 %) |
Jan 09 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Option Exercise | M | 8.30 | 10,000 | 83,000 | 570,000 | |
Jan 09 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.40 | 1,000 | 20,400 | 53,137 | 54.1 K to 53.1 K (-1.85 %) |
Jan 09 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.35 | 1,000 | 20,350 | 54,137 | 55.1 K to 54.1 K (-1.81 %) |
Jan 09 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.31 | 3,000 | 60,930 | 55,137 | 58.1 K to 55.1 K (-5.16 %) |
Jan 09 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.30 | 1,000 | 20,300 | 58,137 | 59.1 K to 58.1 K (-1.69 %) |
Jan 09 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.25 | 1,500 | 30,375 | 59,137 | 60.6 K to 59.1 K (-2.47 %) |
Jan 09 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.20 | 1,500 | 30,300 | 60,637 | 62.1 K to 60.6 K (-2.41 %) |
Jan 09 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.19 | 1,000 | 20,190 | 62,137 | 63.1 K to 62.1 K (-1.58 %) |
Jan 09 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Buy | M | 8.30 | 10,000 | 83,000 | 63,137 | 53.1 K to 63.1 K (+18.82 %) |
Jan 04 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Option Exercise | M | 8.30 | 10,000 | 83,000 | 580,000 | |
Jan 04 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Option Exercise | M | 8.30 | 10,000 | 83,000 | 590,000 | |
Jan 04 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.51 | 2,000 | 41,017 | 53,137 | 55.1 K to 53.1 K (-3.63 %) |
Jan 04 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.53 | 4,000 | 82,120 | 55,137 | 59.1 K to 55.1 K (-6.76 %) |
Jan 04 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.03 | 2,000 | 40,060 | 59,137 | 61.1 K to 59.1 K (-3.27 %) |
Jan 04 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.00 | 2,000 | 40,000 | 61,137 | 63.1 K to 61.1 K (-3.17 %) |
Jan 04 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Buy | M | 8.30 | 10,000 | 83,000 | 63,137 | 53.1 K to 63.1 K (+18.82 %) |
Jan 04 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.29 | 797 | 16,171 | 53,137 | 53.9 K to 53.1 K (-1.48 %) |
Jan 04 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.28 | 200 | 4,056 | 53,934 | 54.1 K to 53.9 K (-0.37 %) |
Jan 04 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.27 | 6,700 | 135,809 | 54,134 | 60.8 K to 54.1 K (-11.01 %) |
Jan 04 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.26 | 1,302 | 26,379 | 60,834 | 62.1 K to 60.8 K (-2.10 %) |
Jan 04 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.25 | 900 | 18,225 | 62,136 | 63 K to 62.1 K (-1.43 %) |
Jan 04 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 20.23 | 101 | 2,043 | 63,036 | 63.1 K to 63 K (-0.16 %) |
Jan 04 2007 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Buy | M | 8.30 | 10,000 | 83,000 | 63,137 | 53.1 K to 63.1 K (+18.82 %) |
Jan 04 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 20.54 | 31 | 637 | 0 | 31 to 0 (-100.00 %) |
Jan 04 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 20.45 | 31 | 634 | 31 | 62 to 31 (-50.00 %) |
Jan 04 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 20.30 | 31 | 629 | 62 | 93 to 62 (-33.33 %) |
Jan 04 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 20.12 | 31 | 624 | 93 | 124 to 93 (-25.00 %) |
Jan 04 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 20.42 | 1 | 20 | 124 | 125 to 124 (-0.80 %) |
Jan 04 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 20.40 | 31 | 632 | 125 | 156 to 125 (-19.87 %) |
Jan 04 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 20.39 | 31 | 632 | 156 | 187 to 156 (-16.58 %) |
Jan 04 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 20.24 | 31 | 627 | 187 | 218 to 187 (-14.22 %) |
Jan 04 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 20.22 | 45 | 910 | 218 | 263 to 218 (-17.11 %) |
Jan 04 2007 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 20.14 | 49 | 987 | 263 | 312 to 263 (-15.71 %) |
Dec 29 2006 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Option Exercise | A | 22.69 | 5,000 | 113,450 | 5,000 | |
Dec 28 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Option Exercise | M | 15.73 | 2,187 | 34,402 | 59,067 | |
Dec 28 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 20.22 | 2,187 | 44,221 | 0 | 2.2 K to 0 (-100.00 %) |
Dec 28 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Buy | M | 15.73 | 2,187 | 34,402 | 2,187 | 0 to 2.2 K |
Dec 28 2006 | PDLI | PDL BIOPHARMA, INC ... | Goodwin Bradford S | Director | Option Exercise | A | 22.69 | 5,000 | 113,450 | 5,000 | |
Dec 22 2006 | PDLI | PDL BIOPHARMA, INC ... | LINK MAX | Director | Option Exercise | A | 22.69 | 5,000 | 113,450 | 5,000 | |
Dec 22 2006 | PDLI | PDL BIOPHARMA, INC ... | GAGE L PATRICK | Director | Option Exercise | A | 22.69 | 5,000 | 113,450 | 5,000 | |
Dec 22 2006 | PDLI | PDL BIOPHARMA, INC ... | Broder Samuel | Director | Option Exercise | A | 22.69 | 5,000 | 113,450 | 5,000 | |
Dec 22 2006 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Option Exercise | A | 22.69 | 5,000 | 113,450 | 5,000 | |
Dec 22 2006 | PDLI | PDL BIOPHARMA, INC ... | DAWES KAREN A | Director | Option Exercise | A | 22.69 | 5,000 | 113,450 | 5,000 | |
Dec 01 2006 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Option Exercise | M | 13.96 | 10,000 | 139,600 | 0 | |
Dec 01 2006 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Option Exercise | M | 7.83 | 10,000 | 78,300 | 0 | |
Dec 01 2006 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 22.84 | 10,000 | 228,400 | 233,178 | 243.2 K to 233.2 K (-4.11 %) |
Dec 01 2006 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Buy | M | 13.96 | 10,000 | 139,600 | 243,178 | 233.2 K to 243.2 K (+4.29 %) |
Dec 01 2006 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 22.85 | 1,821 | 41,610 | 233,178 | 235 K to 233.2 K (-0.77 %) |
Dec 01 2006 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 22.84 | 600 | 13,704 | 234,999 | 235.6 K to 235 K (-0.25 %) |
Dec 01 2006 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 22.83 | 1,374 | 31,368 | 235,599 | 237 K to 235.6 K (-0.58 %) |
Dec 01 2006 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 22.82 | 1,200 | 27,384 | 236,973 | 238.2 K to 237 K (-0.50 %) |
Dec 01 2006 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 22.81 | 5,005 | 114,164 | 238,173 | 243.2 K to 238.2 K (-2.06 %) |
Dec 01 2006 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Buy | M | 7.83 | 10,000 | 78,300 | 243,178 | 233.2 K to 243.2 K (+4.29 %) |
Nov 22 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Option Exercise | M | 17.13 | 645 | 11,049 | 28,420 | |
Nov 22 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 22.75 | 64 | 1,456 | 0 | 64 to 0 (-100.00 %) |
Nov 22 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 22.51 | 250 | 5,628 | 64 | 314 to 64 (-79.62 %) |
Nov 22 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 22.48 | 52 | 1,169 | 314 | 366 to 314 (-14.21 %) |
Nov 22 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 22.45 | 100 | 2,245 | 366 | 466 to 366 (-21.46 %) |
Nov 22 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 22.44 | 50 | 1,122 | 466 | 516 to 466 (-9.69 %) |
Nov 22 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 22.41 | 64 | 1,434 | 516 | 580 to 516 (-11.03 %) |
Nov 22 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 22.37 | 65 | 1,454 | 580 | 645 to 580 (-10.08 %) |
Nov 22 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Buy | M | 17.13 | 645 | 11,049 | 645 | 0 to 645 |
Nov 28 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Option Exercise | M | 15.73 | 2,187 | 34,402 | 61,254 | |
Nov 28 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 23.14 | 365 | 8,446 | 0 | 365 to 0 (-100.00 %) |
Nov 28 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales ... | Sell | S | 23.19 | 362 | 8,395 | 365 | 727 to 365 (-49.79 %) |